Detalhe da pesquisa
1.
Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts.
Am J Hematol
; 96(10): 1211-1222, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34251048
2.
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.
Nature
; 519(7543): 366-9, 2015 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25762141
3.
Ado-trastuzumab emtansine: Avoiding side-effects of traditional HER2 positive breast cancer treatment.
J Oncol Pharm Pract
; 27(7): 1770-1774, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33435824
4.
New onset diabetes with ketoacidosis following nivolumab immunotherapy: A case report and review of literature.
J Oncol Pharm Pract
; 27(3): 716-721, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723064
5.
Treatment exceeds expectations in a patient with non-small cell lung adenocarcinoma with an EGFR exon 20 mutation.
J Oncol Pharm Pract
; 26(1): 206-208, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30760168
6.
Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma.
Am J Hematol
; 94(11): 1244-1253, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31456261
7.
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma.
Oncologist
; 23(8): 889-e98, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29666296
8.
Histologically benign, clinically aggressive: Progressive non-optic pathway pilocytic astrocytomas in adults with NF1.
Am J Med Genet A
; 170(6): 1455-61, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26992069
9.
Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).
Support Care Cancer
; 24(10): 4365-75, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27271867
10.
Paraneoplastic Demyelinating Neuropathy, a Multifactorial Disease and Approach to Management.
Conn Med
; 80(10): 593-595, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29898333
11.
Refractory Small Cell Carcinoma of the Ovary - Hypercalcemic Type (SCCOHT) Treated with Romidepsin and Topotecan: A Case Report and Review of the Literature.
Conn Med
; 80(9): 529-532, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29772136
12.
Kikuchi-Fujimoto Disease in aYoung African American Male: Are we Seeing a Paradigm Shift in Disease Epidemiology? A Case Report.
Conn Med
; 80(7): 409-412, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29782128
13.
Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma.
Oncologist
; 20(7): 727-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26025933
14.
Dual HER2 Blockade in Non-Small Cell Lung Cancer Harboring a HER2 Mutation.
Conn Med
; 79(9): 531-5, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26630704
15.
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans.
Blood
; 118(11): 3003-12, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21768296
16.
O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma.
J Neurooncol
; 114(1): 135-40, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23686298
17.
Leptomeningeal Metastasis from Non-Small Cell Lung Cancer and Current Landscape of Treatments.
Clin Cancer Res
; 29(1): 11-29, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972437
18.
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.
J Clin Oncol
; 41(32): 4945-4952, 2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935104
19.
Bevacizumab and daily temozolomide for recurrent glioblastoma.
Cancer
; 118(5): 1302-12, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21792866
20.
Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.
Cancer
; 118(19): 4759-67, 2012 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22371319